newsfilter
← Latest News
GlobeNewswire·

Geron Plans to Announce Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

FOSTER CITY, Calif., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (NASDAQ:GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that